Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

The Sickle Cell Disease Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

BSH 2022 | An insight into the role of the Sickle Cell Society

In this video, John James, OBE, Sickle Cell Society, London, UK, discusses sickle cell disease (SCD) and its impact on the quality of life of patients. Mr James first highlights the challenges of living with SCD, and then discusses the importance of the Sickle Cell Society in campaigning for more treatment options and aiming to improve the quality of care provided to those with SCD, through campaigning and advocating for patients. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.